Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Therapeutic Potential of Stromal Vascular Fraction (Autologous Adipose Derived Mesenchymal Stem Cell) Based Treatment for Chronic Kidney Disease

NCT03939741 is registered in ClinicalTrials.gov with Bangladesh Laser & Cell Surgery Institute & Hospital as lead sponsor.

NCT NCT03939741
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03939741 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Therapeutic Potential of Stromal Vascular Fraction (Autologous Adipose Derived Mesenchymal Stem Cell) Based Treatment for Chronic Kidney Disease
Lead sponsor
Bangladesh Laser & Cell Surgery Institute & Hospital
Phase
Phase 1/2
Overall status
Unknown status
Start date
April 1, 2019
Completion date
March 31, 2025
Enrollment
31 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney diseases